Press Releases
Washington, D.C. (June 20, 2019)— Yesterday, Chairman Elijah E. Cummings convened the Committee's third hearing on opioids entitled "Medical Experts: Inadequate Federal Approach to Opioid Treatment and the Need to Expand Care."
TAKEAWAYS
Washington, D.C. (June 18, 2019)—On Thursday, June 20, 2019, Rep. Gerry Connolly, the Chairman of the Subcommittee on Government Operations, will hold a hearing to examine longstanding critical deficiencies at the Washington, D.C. Veterans Affairs Medical Center (DC VAMC).
WHERE: 2154 Rayburn House Office Building
WHEN: Thursday, June 20, 2019
TIME: 2:00 p.m. EST
| Washington, D.C. – Today, House Judiciary Chairman Jerrold Nadler (D-NY), Oversight and Reform Chairman Elijah Cummings (D-MD), and Homeland Security Chairman Bennie G. Thompson (D-MS) sent a letter to Acting Secretary of Homeland Security Kevin McAleenan demanding a full explanation regarding the appointment of Ken Cuccinelli to serve as Acting Director of U.S. Citizenship and Immigration Services (USCIS). Full text of the letter is available here and below: |
Washington, D.C. (June 18, 2019)—On Wednesday, June 19, 2019, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, will convene a third hearing on the opioid epidemic, entitled "Medical Experts: Inadequate Federal Approach to Opioid Treatment and the Need to Expand Care."
WASHINGTON, D.C. (June 18, 2019) – U.S. Senator Debbie Stabenow (D-MI), Ranking Member of the Health Subcommittee of the Senate Finance Committee, and U.S. Congressman Elijah Cummings (D-MD), Chairman of the House Oversight and Reform Committee, today called for a Government Accountability Office review of how the Department of Health and Human Services (HHS) prevents pharmaceutical companies from infringing on government-owned patents.
Washington, D.C. (June 18, 2019)— Today, Rep. Elijah E.
| Washington, D.C. (June 13, 2019)— Today, Rep. Elijah E. Cummings, the Chairman of the Oversight and Reform Committee, announced that he will hold a hearing with the Office of Special Counsel after it recommended that President Donald Trump remove Kellyanne Conway from her position at the White House for at least 25 separate violations of the Hatch Act. Chairman Cummings issued the following statement: |
Washington, D.C. (June 13, 2019) – Sen. Bernie Sanders (I-Vt.), Ranking Member of the Senate Budget Committee, and Rep. Elijah E. Cummings (D-Md.), Chairman of the House Committee on Oversight and Reform, wrote to Attorney General William Barr to urge him to investigate 20 generic drug manufacturers for allegedly engaging in an unprecedented, multi-billion-dollar price-fixing conspiracy in violation of federal antitrust law.
Justice and Commerce Refuse to Comply with Bipartisan Subpoenas for Census Documents